Phase 1b study (COSMIC-021) of cabozantinib in combination with atezolizumab:?Results of the dose-escalation stage in ?patients with treatment-naïve advanced ?renal cell carcinoma

Phase 1b study (COSMIC-021) of cabozantinib in combination with atezolizumab:?Results of the dose-escalation stage in ?patients with treatment-naïve advanced ?renal cell carcinoma

kidneycancer

1 year
179 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Neeraj Agarwal Huntsman Cancer Center discusses Phase 1b study (COSMIC-021) of cabozantinib in combination with atezolizumab:?Results of the dose-escalation stage in ?patients with treatment-naïve advanced ?renal cell carcinoma at the Seventeenth International Kidney Cancer International Symposium 2018 in Miami FL.
Up Next Autoplay